Indian scientists demanded to kill cancer cells

Normal body type cancer dies after a period of time. But the human body of the human body, which is the home of the cancer, they should be 'immortal' in some strange rule! They killed the patient without killing themselves. But the mortal man's cancer-stricken cells can not really be immortal! A Bengali scientist, claiming that he has made alternate ways to kill the cancer-stricken cells, to advance with this logic.
Kalipada Pahan, professor and researcher at the University of Chicago, claims that he has invented an antibody named 'Monoclonal', which will help in the elimination of cancer cells. His two associates are Bengalis - Madhukhukta Kundu and Abhik Roy. The discovery of Kalipada Babu has been published in the United States 'Proceedings of National Academy of Sciences' journal.
The scientist reports that many simple sugary cells were also killed during the release of cancer cells in chemotherapy. Side effects are made. In addition to guinea pigs, the results of positive results have been applied by the antibodies produced by the human body on liver, breast, prostate cancer cells. Controlling cancer cells is going to control normal cells. The lung cancer is not working but the antibody works.
Every common cell has its own life span. At one time they died from themselves. Kaliparbabu said that the cells which go to the cancer cell, the cells are not completely exhausted. In his words, "if cancerous cells like ordinary cells die, there will be many benefits. I started to find out why cancer cells are becoming immortal. "
Scientists say that Molekul or Sitokain control the body's immune system, four members of his family. Three members active, one inactive It has been found in the study that inactive cells of cytokine activated in cancerous cells and began to multiply greatly. The inactive member is very active and keeps the cancer cells alive. This is the secret of 'immortality' of cancer cells. The scientists claim that his antibody does not allow the inactive member to proliferate. When the antibody is inserted into the human body, the cancer cell is becoming like a normal cell. Even cancer-stricken cells can not be spread.
Kalipadabu claims that he is talking to the drug company. The drug company will apply for the clearance after buying a patent from him.
"Many studies have been done. But there will be questions about the acceptance of any research before the US Food and Drug Administration's approval, "says Cancer researcher Saikat Gupta. Chittaranjan Kansar Hospital's director Tapash Majhi said, if Kalipada Babu's claim is true then it will be very beneficial for everyone. Mamta Chandi, the Tata Cancer Hospital's director in Kolkata, said that the treatment of the disease came out of the cancer cell. It will not harm other cells. He welcomed Kalipadbabur's research.